[Regulation]Regulation update: Amendments to the Designation of Hazardous Substances (K-REACH)

15 Apr 2026


74da7e751c546.png


We would like to inform you of the changes according to the "Partial Amendment to the Designation of Human Acute Hazardous Substances, Human Chronic Hazardous Substances, and Ecological Hazardous Substances (Notification No. 2026-5)" by the National Institute of Chemical Safety(NICS).

 

Overview

On March 27, 2026, 74 types of human and ecological hazardous substances¹⁾ were newly designated based on the Act on the Registration and Evaluation, etc. of Chemical Substances.

With the enforcement of the regulation on July 1, 2026, obligations to verify and label chemical substances will be imposed across all processes of parts manufacturing.

1) Substances designated as human acute hazardous, human chronic hazardous, and ecological hazardous substances.

 


Key Content

1. Registration of 74 New Hazardous Substances

73 human acute hazardous substances and 1 multi-classified substance were newly designated. (Given Numbers: 2026-1-1281 to 2026-1-1354)

The 1 multi-classified²⁾ substance is Sodium Hypochlorite (CAS 7681-52-9). For this substance only, the regulation will take effect on January 1, 2028.

2) When a single substance simultaneously falls under two or more hazard classifications among human acute, human chronic, and ecological hazards.

 

2. Concentration Limits for Hazardous Chemical Determination

Most new substances are subject to a 10% limit, but some substances are regulated at lower concentrations.

  • 5% Limit: N,N'-Diisopropylethylenediamine, 1-Ethylpiperazine, etc.

  • 2.5% Limit: Sodium Hypochlorite (When applying the ecological hazard standard)

     

3. Revision of Existing Substance Names

The given names of 3 substances, including arsenic and its compounds, have been changed.

  • 97-1-119: Arsenic and its compounds

  • 97-1-379: Fluoroacetic acid and its salts

  • 97-1-417: p-Dimethylaminobenzenediazo sulfonic acid and its salts

     

4. Legal Obligation Deadlines

Businesses that have been handling the newly designated substances prior to the enforcement date of the notification must fulfill their obligations within the following deadlines in accordance with the Chemicals Control Act (CCA).

Phase
Deadline
Key Obligations

Phase 1

Jan 1, 2027

Chemical substance verification, labeling of hazardous chemicals, import declaration of human/ecological hazardous substances, seller notification

Phase 2

Jul 1, 2027

Compliance with hazardous chemical handling standards

Phase 3

Jul 1, 2028

Preparation and submission of chemical accident prevention management plans, business permits and declarations for hazardous chemicals

Phase 4

Jul 1, 2030

Compliance with installation and management standards for hazardous chemical handling facilities


  • For businesses handling Sodium Hypochlorite, a grace period of 1 year and 6 months is added to each of the respective deadlines above.

 


Conclusion

In line with the global trend of strengthening environmental regulations, the scope of domestic hazardous chemical regulations is also continuously expanding.

As the mandatory labeling of hazardous substances goes into full effect in 2027, we strongly recommend minimizing future supply chain risks through preliminary checks of your component data.

 

MDSKorea will continue to do our best to provide useful insights for professionals in the field. 

Thank you.


MDSKorea Inc. 

Head Office: 314, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea

Seoul Office: Digital-ro 26-gil, Guro-gu, Seoul, Korea 

Incheon Office : 22, Inha-ro 489-beon-gil, Namdong-gu, Incheon, Korea 


Copyright ⓒ 2026 MDSKorea Inc. All Rights Reserved

Business Registration No.: 142-81-81626 | E-commerce Registration No.: 2024-YonginSuji-1885 

Representative: Yongyeon Hwang


Request a Consultation

Have questions about our services? 

Submit your inquiry, and our team will get back to you promptly.

MDSKorea Inc.

  Head Office

314, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea

  Seoul Office

173, Digital-ro, Geumcheon-gu, Seoul, Korea 

  Incheon Office

22, Inha-ro 489beon-gil, Namdong-gu, Incheon, Korea 

ⓒ 2023 MDSKorea Inc. All Rights Reserved